Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rositsa Mihaylova, Aleksandar Shkondrov, Denitsa Aluani, Iliana Ionkova, Virginia Tzankova & Ilina Krasteva. (2021)
In vitro antitumour and immunomodulating activity of saponins from Astragalus glycyphyllos
. Biotechnology & Biotechnological Equipment 35:1, pages 1948-1955.
Read now
Read now
Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, Christina Fassnacht, Florentia Dimitriou, Eleni Varypataki, Florian Anzengruber, Mirjam Nägeli, Antonio Cozzio, Reinhard Dummer, Julia Scarisbrick, Steve Pascolo, Wolfram Hoetzenecker, Malgorzata Bobrowicz & Emmanuella Guenova. (2020) Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. OncoImmunology 9:1.
Read now
Read now
Mauro Alaibac. (2018) Small molecule inhibitors for cutaneous T-cell lymphomas. Expert Opinion on Orphan Drugs 6:5, pages 345-350.
Read now
Read now
Mauro Alaibac. (2017) Monoclonal antibodies against cutaneous T-cell lymphomas. Expert Opinion on Biological Therapy 17:12, pages 1503-1510.
Read now
Read now
Articles from other publishers (19)
Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Jasmine Zain, D. Lynne Smith, Oleg E. Akilov, Steven T. Rosen, Mingye Feng & Christiane Querfeld. (2023) Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti−PD-L1 in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology 143:8, pages 1569-1578.e5.
Crossref
Crossref
E. Guenova, P. L. Ortiz‐Romero, B. Poligone & C. Querfeld. (2023) Mechanism of action of chlormethine gel in mycosis fungoides. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Gabriela Blanchard, Francoise Solly, Valentin Basset, Lionel Fontao, Maël Blanchard & Emmanuella Guenova. (2023) Vorinostat for treatment‐refractory bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
G. Blanchard & E. Guenova. (2022) Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma. British Journal of Dermatology 186:1, pages 15-16.
Crossref
Crossref
Malgorzata Bobrowicz, Aleksander Slusarczyk, Joanna Domagala, Michal Dwojak, Desislava Ignatova, Yun‑Tsan Chang, Christoph Iselin, Nina Miazek‑Zapala, Katsiaryna Marhelava, Emmanuella Guenova & Magdalena Winiarska. (2020) Selective inhibition of HDAC6 sensitizes cutaneous T‑cell lymphoma to PI3K inhibitors. Oncology Letters 20:1, pages 533-540.
Crossref
Crossref
Malgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, Yun-Tsan Chang, Florentia Dimitriou & Emmanuella Guenova. (2020) Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020. International Archives of Allergy and Immunology 181:10, pages 733-745.
Crossref
Crossref
Malgorzata Bobrowicz, Radoslaw Zagozdzon, Joanna Domagala, Roberta Vasconcelos-Berg, Emmanuella Guenova & Magdalena Winiarska. (2019) Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives. Cancers 11:10, pages 1420.
Crossref
Crossref
Lilach Moyal, Neta Goldfeiz, Batia Gorovitz, Ada Rephaeli, Efrat Tal, Nataly Tarasenko, Abraham Nudelman, Yael Ziv & Emmilia Hodak. (2017) AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair. Investigational New Drugs 36:1, pages 1-9.
Crossref
Crossref
L. Moyal, S. Yehezkel, B. Gorovitz, A. Keren, A. Gilhar, I. Lubin, S. Sherman & E. Hodak. (2017)
Oncogenic role of microRNA‐155 in mycosis fungoides: an
in vitro
and xenograft mouse model study
. British Journal of Dermatology 177:3, pages 791-800.
Crossref
Crossref
Hiroaki Kamijo, Makoto Sugaya, Naomi Takahashi, Tomonori Oka, Tomomitsu Miyagaki, Yoshihide Asano & Shinichi Sato. (2017) BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines. Archives of Dermatological Research 309:6, pages 491-497.
Crossref
Crossref
Sima Rozati, Phil F. Cheng, Daniel S. Widmer, Kazuyasu Fujii, Mitchell P. Levesque & Reinhard Dummer. (2016) Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL. Clinical Cancer Research 22:8, pages 2020-2031.
Crossref
Crossref
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi & Stefano Pileri. (2016) Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas. Critical Reviews in Oncology/Hematology 99, pages 228-240.
Crossref
Crossref
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi & Stefano Pileri. (2016) Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas. Critical Reviews in Oncology/Hematology 99, pages 214-227.
Crossref
Crossref
Lilach Moyal, Nataly Feldbaum, Neta Goldfeiz, Ada Rephaeli, Abraham Nudelman, Michal Weitman, Nataly Tarasenko, Batia Gorovitz, Leah Maron, Shiran Yehezkel, Iris Amitay-Laish, Ido Lubin & Emmilia Hodak. (2016) The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin. PLOS ONE 11:1, pages e0146115.
Crossref
Crossref
Ieva Saulite, Wolfram Hoetzenecker, Stephan Weidinger, Antonio Cozzio, Emmanuella Guenova & Ulrike Wehkamp. (2016) Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets. BioMed Research International 2016, pages 1-15.
Crossref
Crossref
Catherine G. Chung & Brian Poligone. (2015) Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy. Current Hematologic Malignancy Reports 10:4, pages 468-476.
Crossref
Crossref
S Esmailzadeh, Y Huang, M-W Su, Y Zhou & X Jiang. (2015) BIN1 tumor suppressor regulates Fas/Fas ligand–mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma. Leukemia 29:6, pages 1402-1413.
Crossref
Crossref
R. Dummer, M. Duvic, J. Scarisbrick, E.A. Olsen, S. Rozati, N. Eggmann, S.M. Goldinger, K. Hutchinson, L. Geskin, T.M. Illidge, E. Giuliano, J. Elder & Y.H. Kim. (2014) Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Annals of Oncology 25:9, pages 1807-1812.
Crossref
Crossref
Rudolf Stadler. (2014) Kutane T-Zell-Lymphome: Immer noch eine therapeutische Herausforderung. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 12:8, pages 647-648.
Crossref
Crossref